ENvue Medical, Inc.
Financial highlights
| Metric | FY December 31, 2025 | FY December 31, 2024 | FY December 31, 2023 | FY December 31, 2022 | FY December 31, 2021 |
|---|---|---|---|---|---|
| Revenue | $2.6M | $2.6M | $2.3M | $752,000 | $1.7M |
| Gross profit | $153,000 | $1.5M | $1.5M | $167,000 | $770,000 |
| Operating income | -$22.9M | -$3.6M | -$3.4M | -$5.0M | -$5.7M |
| Operating expenses | $23.0M | $5.1M | $5.0M | $5.2M | $6.5M |
| Cost of revenue | $2.4M | $1.1M | $746,000 | $585,000 | $925,000 |
| Cash from operations | -$9.4M | -$2.5M | -$3.6M | -$7.0M | -$4.4M |
| Capital expenditure | $60,000 | $3,000 | $1,000 | $3,000 | $3,000 |
| Free cash flow | -$9.4M | -$2.5M | -$3.6M | -$7.0M | -$4.4M |
| Share repurchases | $5.0M | — | — | — | — |
| Impairments | $11.2M | $0 | — | — | — |
| Total assets | $41.1M | $3.6M | $6.7M | $5.9M | $8.6M |
| Total liabilities | $7.6M | $3.0M | $2.7M | $2.6M | $2.3M |
Shares outstanding 6.1M · Free float 96.1%
Annual filing data through FY ended December 31, 2025; float as of July 12, 2026.